Literature DB >> 11934875

Expression and characterization of recombinant soluble human CD3 molecules: presentation of antigenic epitopes defined on the native TCR-CD3 complex.

Che-Leung Law1, Martha Hayden-Ledbetter, Sonya Buckwalter, Lisa McNeill, Hieu Nguyen, Phil Habecker, Barbara A Thorne, Raj Dua, Jeffrey A Ledbetter.   

Abstract

The TCR-CD3 complex consists of the clonotypic disulfide-linked TCRalphabeta or TCRdeltagamma heterodimers, and the invariant CD3delta, epsilon, gamma and zeta chains. We generated plasmid constructs expressing the extracellular domains of the CD3delta, epsilon or gamma subunits fused to human IgG1 Fc. Recombinant fusion proteins consisting of individual CD3delta, epsilon or gamma subunits reacted poorly with anti-CD3 mAb including G19-4, BC3, OKT3 and 64.1. Co-expression of the CD3epsilon-Ig with either the CD3delta-Ig (CD3epsilondelta-Ig) or the CD3gamma-Ig (CD3epsilongamma-Ig) resulted in fusion proteins with much increased binding to G19-4. A brief acid treatment of the purified CD3epsilondelta-Ig fusion protein substantially improved its binding to BC3, OKT3 and 64.1. Surface plasmon resonance analysis revealed that the dissociation constants for CD3epsilondelta-Ig and anti-CD3 mAb ranged from 10(-8) to 10(-9) M. Based on these results, a single-chain (sc) construct encoding the CD3delta chain linked to the CD3epsilon chain with a flexible linker followed by human IgG1 Fc was expressed. The sc CD3deltaepsilon-scIg reacted with anti-CD3 mAb without requiring acid treatment. Moreover, anti-CD3 mAb bound CD3epsilondelta-Ig at a higher affinity than CD3epsilongamma-Ig, suggesting potential structural differences between the CD3epsilondelta and CD3epsilongamma subunits. In summary, we report the expression of soluble recombinant CD3 proteins that demonstrate structural characteristics of the native CD3 complex expressed on the T cell surface. These CD3 fusion proteins can be used to further analyze the structure of the TCR-CD3 complex, and to identify molecules that can interfere with TCR-CD3-mediated signal transduction by disrupting the interaction between CD3 and TCR subunits.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11934875     DOI: 10.1093/intimm/14.4.389

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  7 in total

1.  Retargeting T cells to GD2 pentasaccharide on human tumors using Bispecific humanized antibody.

Authors:  Hong Xu; Ming Cheng; Hongfen Guo; Yuedan Chen; Morgan Huse; Nai-Kong V Cheung
Journal:  Cancer Immunol Res       Date:  2014-12-26       Impact factor: 11.151

2.  Expression and characterization of recombinant soluble porcine CD3 ectodomain molecules: mapping the epitope of an anti-porcine CD3 monoclonal antibody 898H2-6-15.

Authors:  Jaclyn Stromp Peraino; Christina E Hermanrud; Lauren Springett; Huiping Zhang; Guoying Li; Srimathi Srinivasan; Ashley Gusha; David H Sachs; Christene A Huang; Zhirui Wang
Journal:  Cell Immunol       Date:  2012-05-18       Impact factor: 4.868

3.  Bispecific antibodies targeting mutant RAS neoantigens.

Authors:  Jacqueline Douglass; Emily Han-Chung Hsiue; Brian J Mog; Michael S Hwang; Sarah R DiNapoli; Alexander H Pearlman; Michelle S Miller; Katharine M Wright; P Aitana Azurmendi; Qing Wang; Suman Paul; Annika Schaefer; Andrew D Skora; Marco Dal Molin; Maximilian F Konig; Qiang Liu; Evangeline Watson; Yana Li; Michael B Murphy; Drew M Pardoll; Chetan Bettegowda; Nickolas Papadopoulos; Sandra B Gabelli; Kenneth W Kinzler; Bert Vogelstein; Shibin Zhou
Journal:  Sci Immunol       Date:  2021-03-01

4.  The Affinity of Elongated Membrane-Tethered Ligands Determines Potency of T Cell Receptor Triggering.

Authors:  Bing-Mae Chen; Mohammad Ameen Al-Aghbar; Chien-Hsin Lee; Tien-Ching Chang; Yu-Cheng Su; Ya-Chen Li; Shih-En Chang; Chin-Chuan Chen; Tsai-Hua Chung; Yuan-Chun Liao; Chau-Hwang Lee; Steve R Roffler
Journal:  Front Immunol       Date:  2017-07-10       Impact factor: 7.561

5.  High-Affinity Ligands Can Trigger T Cell Receptor Signaling Without CD45 Segregation.

Authors:  Mohammad Ameen Al-Aghbar; Yeh-Shiu Chu; Bing-Mae Chen; Steve R Roffler
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

6.  The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity.

Authors:  Christopher W Helsen; Joanne A Hammill; Vivian W C Lau; Kenneth A Mwawasi; Arya Afsahi; Ksenia Bezverbnaya; Lisa Newhook; Danielle L Hayes; Craig Aarts; Bojana Bojovic; Galina F Denisova; Jacek M Kwiecien; Ian Brain; Heather Derocher; Katy Milne; Brad H Nelson; Jonathan L Bramson
Journal:  Nat Commun       Date:  2018-08-03       Impact factor: 14.919

7.  A soluble activator that favors the ex vivo expansion of CD8+CD27+ T cells.

Authors:  Esther I Matus; Amanda Sparkes; Jean Gariépy
Journal:  JCI Insight       Date:  2020-11-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.